Inactive Instrument

Company Cadila Healthcare Limited NSE India S.E.

Equities

INE010B01019

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Cadila Healthcare Limited

Business Summary

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
87.0 %
132,864 87.0 % 149,926 87.0 % +12.84%
Consumer Products
13.0 %
19,788 13.0 % 22,448 13.0 % +13.44%

Sales per region

INR in Million2022Weight2023Weight Delta
India
44.3 %
72,532 47.5 % 76,399 44.3 % +5.33%
United States
43.4 %
59,487 39.0 % 74,868 43.4 % +25.86%
Others
12.2 %
20,633 13.5 % 21,107 12.2 % +2.30%

Managers

Managers TitleAgeSince
Chief Executive Officer 44 97-07-31
Director of Finance/CFO - -
Chairman 71 95-05-14
Compliance Officer - 19-02-06
Director/Board Member 68 76-12-31
Investor Relations Contact - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 72 18-12-05
Chairman 71 95-05-14
Director/Board Member 69 97-07-31
Chief Executive Officer 44 97-07-31
Director/Board Member 55 03-08-15
Director/Board Member 68 76-12-31
Director/Board Member 44 22-11-28
Director/Board Member 81 11-05-05
Director/Board Member 68 14-05-15
Director/Board Member 37 22-11-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,006,233,990 250,227,197 ( 24.87 %) 0 24.87 %

Shareholders

NameEquities%Valuation
758,788,706 75.41 % 9 146 M ₹
Life Insurance Corporation of India (Investment Portfolio)
6.015 %
60,525,602 6.015 % 730 M ₹
Kotak Mahindra Asset Management Co. Ltd.
2.350 %
23,650,108 2.350 % 285 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.8731 %
8,785,008 0.8731 % 106 M ₹
PPFAS Asset Management Private Ltd.
0.8004 %
8,054,030 0.8004 % 97 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.6062 %
6,099,681 0.6062 % 74 M ₹
Tata Asset Management Ltd.
0.5787 %
5,822,631 0.5787 % 70 M ₹
Sundaram Asset Management Co. Ltd.
0.3309 %
3,329,528 0.3309 % 40 M ₹
HDFC Life Insurance Co. Ltd. (Investment Portfolio)
0.2650 %
2,666,921 0.2650 % 32 M ₹
HSBC Asset Management (India) Pvt Ltd.
0.2005 %
2,017,500 0.2005 % 24 M ₹

Holdings

NameEquities%Valuation
36,647,509 57.59% 646,321,332 $

Company contact information

Zydus Lifesciences Ltd.

Zydus Corporate Park Scheme No. 63, Survey No. 536

382481, Ahmedabad

+91 79 7180 0000

http://www.zyduscadila.com
address Cadila Healthcare Limited

Group companies

NameCategory and Sector
Food: Major Diversified
Medical Distributors
Pharmaceuticals: Major
Pharmaceuticals: Other
Zydus Vtec Ltd.
  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. Stock
  5. Company Cadila Healthcare Limited